*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Katherine Nguyen
BME PhD Proposal Presentation
Date:2022-06-27
Time: 12:00 PM-2:00 PM
Location / Meeting Link: EBB 4029 or https://gatech.zoom.us/j/99810303612?pwd=alBTS1V6Y2lScHNBM0tKSCtYSkIydz09
Committee Members:
Shuichi Takayama, PhD (Advisor) Jason Knight, MD, PhD Wilbur Lam, MD, PhD Rebecca Levit, MD Aniruddh Sarkar, PhD
Title: A High-throughput Degradation Assay Using Mimetic Neutrophil Extracellular Traps (NETs) to Study How DNase and Proteases Work Simultaneously to Clear NETs
Abstract:
Neutrophil extracellular traps (NETs) are decondensed chromatin with granule proteins released by neutrophils. While NETs were initially thought to be a bacteria killing method, interest in NETs grew as further research that NETs are involved in a large variety of pathologies such as sepsis, infections, autoimmune disorders, cardiovascular diseases, pulmonary diseases, and even cancer. In these conditions, over production or improper clearance of NETs were often tied to disease severity. Thus, there is a possibility for new treatments that target and degrade NETs. However more knowledge about NET degradation modulators is necessary to develop the treatments. Current degradation studies mostly focus on DNases found in serum despite a growing opinion of the possibility of protease mediated degradation. Therefore, the objective of this proposal is to create a high-throughput assay using mimetic NETs to study how serum DNases and proteases work simultaneously to clear NETs. In aim 1, we will create synthetic NET-like structures referred to as surface-webs to create a fluorescence-based assay suitable for high throughput studies. Then, we will characterize the role of common serum proteases on NET degradation. Finally, the surface-webs will be used to analyze NET degradation by proteases in clinical serum samples. Success of this proposal will identify a new target for NET degrading therapeutics and simultaneously create a convenient assay for further NET research.
